Immune Management ApS: Financial statements 2017
CVR: 38726137
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Immune Management ApS (CVR 38726137) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 818,378 and a net result of DKK 111,372. Equity in the 2017 report amounted to DKK 358,052. The solvency ratio was 68.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 818,378
- Profit/Loss
- DKK 111,372
- Equity
- DKK 358,052
- Total Assets
- DKK 524,927
- Employees
- 1
Official annual report
Keep an eye on Immune Management ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 19, 2017, Nadjie Kit Ulrich Bojko is registered as director of Immune Management ApS.
Immune Management ApS was founded on June 19, 2017.
About Immune Management ApS
Immune Management ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2017. The company has been dissolved on 2 December 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -13,493 and a net result of DKK -15,195 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK 41,224.